| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(05)81705-6 |
| P698 | PubMed publication ID | 8345429 |
| P2093 | author name string | Wang E | |
| Andrew M | |||
| Watts J | |||
| Ohlsson A | |||
| Saigal S | |||
| Milner R | |||
| Kirpalani H | |||
| Caco C | |||
| Vegh P | |||
| Jefferies A | |||
| P2860 | cites work | A New Design for Randomized Clinical Trials | Q28239541 |
| Intraventricular hemorrhage in the premature infant--current concepts. Part I | Q28284313 | ||
| The quantitative relation between platelet count and hemorrhage in patients with acute leukemia | Q33353564 | ||
| Favorable neurological outcome in 7 cases of perinatal intracranial hemorrhage due to immune thrombocytopenia. | Q33391260 | ||
| Thrombocytopenia with absent radii. A review of 100 cases. | Q33445890 | ||
| Prenatal diagnosis and management of bleeding disorders with fetal blood sampling | Q33450825 | ||
| Frequency and mechanism of neonatal thrombocytopenia | Q33455586 | ||
| Clinical impact of neonatal thrombocytopenia | Q33457027 | ||
| Prophylactic Platelet Transfusions in Children with Acute Leukemia: A Dose Response Study | Q33466322 | ||
| Platelet dysfunction and coagulopathy in intraventricular hemorrhage in the premature infant | Q33484161 | ||
| Thrombocytopenia in the high-risk infant | Q33487166 | ||
| An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus | Q35596833 | ||
| Intraventricular haemorrhage and haemostasis defects | Q38946089 | ||
| Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm | Q40671726 | ||
| Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation | Q41355351 | ||
| Prevention of intraventricular haemorrhage by fresh frozen plasma | Q42116200 | ||
| Etiopathology and classification of acquired coagulation disorders in the newborn infant | Q45200136 | ||
| No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparin | Q47431782 | ||
| Fibrinolytic Activity in the Ganglionic Eminence of the Premature Human Brain | Q48859568 | ||
| Capillary-blood coagulation profile in the newborn. | Q53735005 | ||
| Anticoagulant effects of heparin in neonatal plasma. | Q54356155 | ||
| THROMBOCYTOPENIA WITH ABSENT RADIUS (TAR) | Q56171985 | ||
| Thrombin inhibition is impaired in plasma of sick neonates | Q67534701 | ||
| Platelet transfusion therapy | Q68496759 | ||
| Evaluation of an automated bleeding time device in the newborn | Q68602411 | ||
| 'Normal' haemostasis parameters: a study in a well-defined inborn population of preterm infants | Q70793309 | ||
| Acquired haemostatic defects in the ill newborn | Q71727034 | ||
| Establishing reference ranges of cord blood: point-of-care hemostatic function assessment in preterm and term neonates | Q104501923 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombocytopenia | Q585285 |
| randomized controlled trial | Q1436668 | ||
| preterm infant | Q45051448 | ||
| P304 | page(s) | 285-291 | |
| P577 | publication date | 1993-08-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants | |
| P478 | volume | 123 |
| Q33403594 | A consistent approach to platelet transfusion in the NICU. |
| Q50540044 | A multidisciplinary "think tank": the top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium. |
| Q71589733 | A randomized trial comparing the effect of prophylactic intravenous fresh frozen plasma, gelatin or glucose on early mortality and morbidity in preterm babies. The Northern Neonatal Nursing Initiative [NNNI] Trial Group |
| Q33579189 | A survey of Canadian neonatal blood transfusion practices |
| Q24186913 | A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation |
| Q33382246 | Advances and controversies in neonatal ICU platelet transfusion practice |
| Q52643460 | Association between Platelet Counts before and during Pharmacological Therapy for Patent Ductus Arteriosus and Treatment Failure in Preterm Infants. |
| Q37605875 | Beyond randomized controlled trials in attempted suicide research |
| Q51612929 | C-reactive protein, platelets, and patent ductus arteriosus. |
| Q41392293 | Changing the default for tobacco-cessation treatment in an inpatient setting: study protocol of a randomized controlled trial |
| Q46573703 | Clinical Trial Opportunities in Transfusion Medicine: Proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium |
| Q57689300 | Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders |
| Q24187751 | Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation |
| Q36695955 | Current Perspectives on Pathobiology of the Ductus Arteriosus |
| Q24186359 | Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation |
| Q33409352 | Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice |
| Q33376672 | Do platelet transfusions in the NICU adversely affect survival? Analysis of 1600 thrombocytopenic neonates in a multihospital healthcare system. |
| Q33406651 | Do we know when to treat neonatal thrombocytopaenia? |
| Q92022500 | Dynamic prediction of bleeding risk in thrombocytopenic preterm neonates |
| Q24247166 | Early volume expansion for prevention of morbidity and mortality in very preterm infants |
| Q33394140 | Effects of in vitro adult platelet transfusions on neonatal hemostasis |
| Q33396911 | Evidence-based platelet transfusion recommendations in neonates |
| Q53674609 | Guidelines on transfusion for fetuses, neonates and older children. |
| Q33342424 | HPA-1 carrier status and thrombocytopenia in preterm infants with a birth weight below 1500 grams |
| Q33397361 | How I manage neonatal thrombocytopenia |
| Q33378272 | How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity |
| Q38055209 | How we decide when a neonate needs a transfusion |
| Q33443269 | Imaging and management of fetuses and neonates with alloimmune thrombocytopenia |
| Q33348204 | Inter-NICU variation in rates and management of thrombocytopenia among very low birth-weight infants |
| Q28200791 | Interleukin-11 levels in healthy and thrombocytopenic neonates |
| Q33395092 | Is a small platelet mass associated with intraventricular hemorrhage in very low-birth-weight infants? |
| Q33395211 | Maternal preeclampsia and neonatal outcomes |
| Q89643600 | Neonatal Thrombocytopenia and the Role of the Platelet Mass Index in Platelet Transfusion in the Neonatal Intensive Care Unit |
| Q90016772 | Neonatal and pediatric platelet transfusions: current concepts and controversies |
| Q26852908 | Neonatal platelets: mediators of primary hemostasis in the developing hemostatic system |
| Q24673677 | Neonatal thrombocytopenia: causes and management |
| Q33414184 | Neonatal thrombocytopenia: etiology, management and outcome |
| Q35556499 | Neonatal transfusion practice |
| Q35535157 | One size will never fit all: the future of research in pediatric transfusion medicine |
| Q63916614 | Ontogeny of platelet function |
| Q33333554 | Perinatal thrombocytopenia of maternal origin |
| Q33432436 | Platelet Transfusion Practices Among Very-Low-Birth-Weight Infants. |
| Q27013796 | Platelet Transfusions in the Neonatal Intensive Care Unit |
| Q33499533 | Platelet disorders in newborn infants: diagnosis and management |
| Q33424354 | Platelet mass index: is it a hope for reduction of platelet transfusion in NICU? |
| Q33342076 | Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients |
| Q33397559 | Platelet transfusion in the neonatal intensive care unit: benefits, risks, alternatives |
| Q33488344 | Platelet transfusion therapy in newborn infants |
| Q54469295 | Platelet transfusion volume reduction: it can be done, but why do it? |
| Q33363972 | Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity |
| Q33395699 | Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland |
| Q38176626 | Preventing germinal matrix layer rupture and intraventricular hemorrhage |
| Q36493713 | Prevention of intraventricular haemorrhage: a role for recombinant activated factor VII? |
| Q33425531 | Prognostic significance of early platelet count decline in preterm newborns |
| Q24245960 | Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation |
| Q24197779 | Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation |
| Q55154097 | Recent advances in transfusions in neonates/infants. |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
| Q26786617 | Recommendations for transfusion therapy in neonatology |
| Q34984870 | Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment |
| Q33403712 | Restrictive guideline reduces platelet count thresholds for transfusions in very low birth weight preterm infants |
| Q24236017 | Strategies to improve recruitment to randomised controlled trials |
| Q50104975 | Strategies to improve recruitment to randomised trials |
| Q35052797 | The ACCESS study a Zelen randomised controlled trial of a treatment package including problem solving therapy compared to treatment as usual in people who present to hospital after self-harm: study protocol for a randomised controlled trial |
| Q37004208 | The effectiveness of Multidimensional Treatment Foster Care for Preschoolers (MTFC-P) for young children with severe behavioral disturbances: study protocol for a randomized controlled trial. |
| Q33403539 | The prevalence and outcomes of thrombocytopenia in a neonatal intensive care unit: a three-year report |
| Q31038266 | Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system |
| Q33394096 | Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study |
| Q33374735 | Thrombocytopenia related neonatal outcome in preterms |
| Q40998004 | What's new in transfusion medicine? |
Search more.